L-748,337
Names
Biological Activity
[Description]:
L748337 is a potent β3-adrenergic receptor antagonist and displays selectivity over β1 and β2 receptors. The Ki values of L748337 for β3-, β2- and β1-adrenoceptors are 4.0 nM, 204 nM and 390 nM, respectively[1]. L748337 couples predominantly to Gi to activate MAPK signaling and increases phosphorylation of Erk1/2 with pEC50 value of 11.6[2]. L748337 can be used for the research of cancer, nonalcoholic fatty liver disease (NAFLD), and cardiovascular related diseases[1][2][3].
[Related Catalog]:
[Target]
Beta-3 adrenergic receptor:4 nM (Ki)
Beta-2 adrenergic receptor:204 nM (Ki)
Beta-1 adrenergic receptor:390 nM (Ki)
[In Vitro]
L748337 (1 μM) inhibits iNOS expression in B16F10 cells[1].
[In Vivo]
L-748337 (intraperitoneal injection; 5 mg/kg; beginning 10 days until D18) decreases the growth of melanoma induced by B16F10 cell inoculation and decreases tumor vasculature in mice[1]. Animal Model: Fifty male C57BL/6 J mice (8 weeks of age) bearing syngeneic B16F10 cell[1] Dosage: 5 mg/kg Administration: Beginning 10 days until D18 Result: Exhibited anti-cancer effects.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C26H31N3O5S
[ Molecular Weight ]:
497.60600
[ Exact Mass ]:
497.19800
[ PSA ]:
125.14000
[ LogP ]:
4.63110
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.